← back to search

Yuanyuan Zhao

Shanxi Medical University · CN
Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Cells and Metastasis, Cancer Immunotherapy and Biomarkers, Mesenchymal stem cell research, and Extracellular vesicles in disease.
h-index
28
citations
3,282
works
124
NIH funding
primary concept
email

Recent publications

Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway
Molecular Immunology 2025cited by 4position: middledoi
Spatial relationships and interactions of immune cell niches are linked to the pathologic response of muscle-invasive bladder cancer to neoadjuvant therapy
Journal of Translational Medicine 2025cited by 3position: middledoi
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis
Journal for ImmunoTherapy of Cancer 2024cited by 25position: firstdoi
FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression
International Immunopharmacology 2024cited by 11position: middledoi
Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression
Stem Cell Reviews and Reports 2024cited by 9position: middledoi
Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells
Journal of Cellular Biochemistry 2024cited by 5position: middledoi
<b>Experts' </b><b>C</b><b>ognition-Driven Ensemble Deep Learning </b><b>f</b><b>or External Validation of Predicting Pathological Complete Response to Neoadjuvant Chemotherapy </b><b>f</b><b>rom Histological Images in Breast Cancer</b>
Medinformatics 2024cited by 4position: middledoi
Bnip3 promotes the release of mitochondria-derived extracellular vesicles in cardiac fibroblasts to exacerbate inflammation response after myocardial infarction
European Heart Journal 2024cited by 1position: middledoi
Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression
Gastric Cancer 2023cited by 39position: middledoi
Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer
Cellular Signalling 2023cited by 23position: middledoi
Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation
Experimental Cell Research 2023cited by 19position: middledoi
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients
Breast Cancer Research and Treatment 2023cited by 10position: middledoi
hsa_circ_0005991 promotes epithelial-mesenchymal transition by regulating miR-30b-3p/Cdc42EP1 axis in ovary endometriosis
Genomics 2023cited by 5position: middledoi
Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
npj Breast Cancer 2022cited by 31position: middledoi
Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells
Frontiers in Immunology 2022cited by 16position: middledoi
Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression
Experimental Cell Research 2022cited by 16position: middledoi
Gastric cancer-derived exosomes induce PD-L1 expression on human bone marrow mesenchymal stem cells through the AKT-c-Myc signal axis
All Life 2022cited by 9position: middledoi
Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review)
Experimental and Therapeutic Medicine 2021cited by 41position: middledoi
G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
Frontiers in Oncology 2021cited by 31position: middledoi
Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth
Stem Cells International 2021cited by 27position: middledoi
Gastric cancer mesenchymal stem cells inhibitnatural killer cell function by up-regulating FBP1
Central European Journal of Immunology 2021cited by 20position: middledoi
Identification of Gingivitis-Related Genes Across Human Tissues Based on the Summary Mendelian Randomization
Frontiers in Cell and Developmental Biology 2021cited by 8position: middledoi
Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis
Theranostics 2020cited by 87position: middledoi
Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cell Exosomes Reduce Hepatic Ischemia/Reperfusion Injury by Enhancing Autophagy
Stem Cells and Development 2020cited by 46position: middledoi
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects
Stem Cells and Development 2019cited by 62position: middledoi
Ovarian Sclerosing Stromal Tumor and Müllerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature
International Journal of Gynecological Pathology 2019cited by 6position: middledoi
Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
Cell Death and Disease 2018cited by 150position: middledoi
Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7
International Journal of Molecular Medicine 2018cited by 59position: middledoi
Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4 <sup>+</sup> T Cell
Stem Cells and Development 2018cited by 41position: middledoi
Platelets enhance the ability of bone-marrow mesenchymal stem cells to promote cancer metastasis
OncoTargets and Therapy 2018cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wei Zhu · Beijing Information Science & Technology University17 papers (2015–2025)Mei Wang · Jiangsu University14 papers (2017–2024)Wenrong Xu · Jiangsu University13 papers (2015–2023)Chao‐Yuan Huang · Hebei Medical University13 papers (2020–2025)Qianqian Wang · Fudan University10 papers (2018–2023)Li Sun · Jiangsu University8 papers (2017–2024)Qiuzhi Gao · Jiangsu University8 papers (2019–2024)Bo Shen · Nantong University7 papers (2018–2023)Chenglin Zhou · Nanjing University of Chinese Medicine6 papers (2022–2025)Changgen Xu · Jilin University6 papers (2017–2018)Bo Shen · Zhejiang University6 papers (2017–2023)Wei Zhu · Jiangsu University6 papers (2021–2023)Xiangdong Zhao · Hebei General Hospital6 papers (2017–2018)Deqiang Wang · Guangzhou University of Chinese Medicine6 papers (2023–2025)Shuwei Guo · Jiangsu University5 papers (2020–2022)Zhihong Chen · Affiliated Hospital of North Sichuan Medical College5 papers (2018–2024)Miaolin Zhu · Jiangsu University5 papers (2018–2021)Xiaoxian Sun · Jiangsu University4 papers (2015–2017)Linjing Cui · Jiangsu University4 papers (2021–2024)Li Sun · Medical College of Wisconsin4 papers (2015–2018)